Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperphosphatemia in Chronic Kidney Disease”

105 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 105 results

Early research (Phase 1)Study completedNCT01057108
What this trial is testing

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Denver Nephrologists, P.C. 121
Post-approval studies (Phase 4)Study completedNCT00160121
What this trial is testing

Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease

Who this might be right for
Kidney Failure, Chronic
Shire 2,500
Not applicableStudy completedNCT07180069
What this trial is testing

Phosphate Diet Strategies to Lower Blood Phosphate in Dialysis Patients

Who this might be right for
HyperphosphataemiaPhosphorusDiet Therapy+1 more
Kufa University 200
Post-approval studies (Phase 4)Study completedNCT04549597
What this trial is testing

Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia

Who this might be right for
Chronic Kidney Disease Requiring Chronic DialysisHyperphosphatemia
Ardelyx 333
Large-scale testing (Phase 3)UnknownNCT03202407
What this trial is testing

Hyperphosphatemia in Children With Chronic Kidney Disease

Who this might be right for
Hyperphosphatemia
Assiut University 40
Post-approval studies (Phase 4)Ended earlyNCT00452478
What this trial is testing

Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5

Who this might be right for
Kidney Diseases
Shire 68
Testing effectiveness (Phase 2)UnknownNCT02469467
What this trial is testing

A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

Who this might be right for
End Stage Renal DiseaseHyperphosphatemia
KDL Inc. 30
Not applicableStudy completedNCT01901107
What this trial is testing

Post-marketing Surveillance of Kiklin Capsules in Hemodialysis Patients

Who this might be right for
Chronic Renal Failure Patients With Hyperphosphataemia Receiving Hemodialysis
Astellas Pharma Inc 1,078
Testing effectiveness (Phase 2)UnknownNCT00834301
What this trial is testing

An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients

Who this might be right for
HyperphosphatemiaInflammationRenal Disease
Nephrian 25
Large-scale testing (Phase 3)Study completedNCT01578200
What this trial is testing

Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark Study

Who this might be right for
HemodialysisHyperphosphatemia
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 2,309
Testing effectiveness (Phase 2)Study completedNCT00317694
What this trial is testing

Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients

Who this might be right for
Chronic Kidney Failure
Ineos Healthcare Limited 111
Large-scale testing (Phase 3)UnknownNCT01357317
What this trial is testing

Study Comparing Effects of Lanthanum Carbonate Versus Calcium Acetate Versus Dietary Phosphorus Restriction

Who this might be right for
Chronic Kidney Disease
Salem Veterans Affairs Medical Center 120
Large-scale testing (Phase 3)Study completedNCT01503736
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

Who this might be right for
HyperphosphatemiaEnd Stage Renal DiseaseESRD
Panion & BF Biotech Inc. 183
Post-approval studies (Phase 4)Study completedNCT03256838
What this trial is testing

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

Who this might be right for
Kidney Failure, ChronicEnd-stage Renal DiseasePhosphorus Metabolism Disorders+1 more
Panion & BF Biotech Inc. 202
Large-scale testing (Phase 3)Study completedNCT00772382
What this trial is testing

Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 116
Testing effectiveness (Phase 2)Looking for participantsNCT06712654
What this trial is testing

Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Who this might be right for
HyperphosphatemiaChronic Kidney Disease Requiring Chronic DialysisEnd Stage Renal Disease on Dialysis
R1 Therapeutics 168
Large-scale testing (Phase 3)Ended earlyNCT00451295
What this trial is testing

A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia
Tanabe Pharma Corporation 6
Large-scale testing (Phase 3)Study completedNCT01742611
What this trial is testing

Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Who this might be right for
Chronic Kidney DiseaseRenal InsufficiencyHyperphosphatemia
Astellas Pharma Inc 105
Testing effectiveness (Phase 2)Study completedNCT05764590
What this trial is testing

Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia Patients

Who this might be right for
Chronic Kidney DiseasesHyperphosphatemia
Alebund Pharmaceuticals 55
Large-scale testing (Phase 3)Study completedNCT01464190
What this trial is testing

Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients

Who this might be right for
Chronic Kidney Disease Requiring Chronic Dialysis
Vifor Pharma 659
Next Page